Please Wait
Applying Filters...
menu
    • menu
    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Buntanetap

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2917931/0/en/Annovis-Bio-Secures-U-S-Patent-for-Treatment-of-Acute-Traumatic-Brain-Injury-with-Buntanetap.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913695/0/en/Annovis-Bio-Receives-FDA-Approval-to-Transition-to-New-Crystal-Form-of-Buntanetap.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share
    Annovis Bio Announces New Data From Phase III Parkinson's Study
    Annovis Bio Announces New Data From Phase III Parkinson's Study

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907365/0/en/Annovis-Bio-Announces-New-Data-from-Phase-III-Parkinson-s-Study-Highlighting-Improvements-in-Unified-Parkinson-s-Disease-Rating-Scale-MDS-UPDRS-and-Cognition-after-Treatment-with-B.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap
    Annovis Bio Files Patent for New Composition of Matter for Buntanetap

    26 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/26/2904442/0/en/Annovis-Bio-Files-Patent-for-New-Composition-of-Matter-for-Buntanetap.html

    GLOBENEWSWIRE
    26 Jun 2024
    Share Share
    Annovis Bio’s Buntanetap Found Safe &Effective in High-Risk Alzheimer's Patients
    Annovis Bio’s Buntanetap Found Safe &Effective in High-Risk Alzheimer's Patients

    11 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/11/2896720/0/en/Annovis-Bio-s-Buntanetap-Found-Safe-and-Effective-in-High-Risk-Alzheimer-s-Patients.html

    GLOBENEWSWIRE
    11 Jun 2024
    Share Share
    Annovis Unblinded Buntanetap Phase 3 Parkinson's Data
    Annovis Unblinded Buntanetap Phase 3 Parkinson's Data

    09 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/09/2878650/0/en/Annovis-Announces-Unblinding-of-the-Buntanetap-Phase-III-Data-in-Parkinson-s-Disease.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share